Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies
17.02.2022 - Collaboration Enables Further Expansion of Mass Cytometry in the Middle EastSOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) - Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life ... Seite 1
Yendry Ventura Carmenate Middle East General Manager Fluidigm Maxpar Direct Immune Profiling Assay Hyperion Imaging System
Source: wallstreet-online.de